Skip to main content

CRISPR Knock-in Mouse Debuts

Researchers have created a line of model mice that naturally express Cas9, paving the way for rapid precision gene-editing.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA, RAMAThe work of researchers who use the CRISPR gene-editing technique to precisely clip genetic sequences from mouse chromosomes just got a little bit easier. Scientists at the Broad Institute of MIT and Harvard have unveiled the “Cas9 mouse,” a model organism that naturally expresses Cas9, the cleaving enzyme that cuts DNA in exact spots along the genome with the help of a guide RNA. Currently, using CRISPR means injecting both Cas9 and guide RNA into cells to edit a specific part of the genome. But with Cas9 mice, researchers will only have to inject the guide RNA, which pilots the Cas9 to the target gene sequence, in order to alter virtually any part of the mouse genome.

This will allow quicker and easier gene knock-down experiments, for example, because having on-board Cas9 makes more room in vectors used to deliver the guide RNA to contain multiple instructions for genome editing in the knock-in mice. “By equipping the mouse with Cas9, we relieved the burden of delivery,” MIT’s Randall Platt, a coauthor on the September 25 Cell paper announcing the creation of the Cas9 mouse, said in a statement. “This frees up space for the delivery of additional elements—whether by viruses or nanoparticles—making it possible to simultaneously mutate multiple genes and even make precise changes in DNA sequences.”

No longer will researchers seeking to mouse lines that model human cancers, for instance, have to inactivate one gene at a time or cross animals ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays